FDA And CMS Agree To Share Data Routinely In Step Toward Parallel Reviews
Executive Summary
A June 23 memorandum of understanding on data sharing could serve as a first step toward parallel reviews by FDA and CMS for marketing approval and Medicare coverage, according to FDA
You may also be interested in...
FDA/CMS Data Sharing Encouraged In Senate Appropriations Report
Senate appropriators are pushing for more interaction between FDA and the Centers for Medicare and Medicaid Services during medical product reviews.
FDA/CMS Data Sharing Encouraged In Senate Appropriations Report
Senate appropriators are pushing for more interaction between FDA and the Centers for Medicare and Medicaid Services during medical product reviews.
CER Has Been A Part Of CMS Coverage Decisions In Recent Years – Avalere
During the health care reform debate, much concern was expressed that results of comparative effectiveness research from the Patient-Centered Outcomes Research Institute could play a key role in Medicare coverage decisions. But CER has already been considered in making Medicare coverage decisions for years, recent Avalere Health analysis of national coverage determinations issued by CMS points out.